June 8, 2022
Ten years ago, Shelley Frisbie’s husband received a diagnosis of metastatic cancer and was told he had six months to live. Shelley and her husband immediately faced immense urgency and uncertainty. But with guidance from Cancer Commons founder Marty Tenenbaum, PhD, Shelley soon had a list of top resources, doctors, and medical institutions to consult for help with her husband’s case. “I now had… Read more »
October 1, 2018
What to Expect When Active Surveillance Leads to Prostatectomy BookmarkEmma Shtivelman, PhD
Excerpt from MedPage Today:
“A high proportion of men who entered active surveillance for early prostate cancer had one or more high-risk disease characteristics when they subsequently had radical prostatectomy, a Swedish study showed.
“Medical records showed that 52 of 132 men had at least one adverse pathology feature at radical prostatectomy. All the men initially opted for active surveillance, and the median time from enrollment to surgery was 1.9 years.”
September 25, 2018
Tool Predicts Risk for Late Breast Cancer Recurrence BookmarkEmma Shtivelman, PhD
Excerpt from Healio:
“An online prognostic tool accurately determined the risk for late distant recurrence among women with ER-positive breast cancer, according to a single-arm, prospective study.
“The Clinical Treatment Score post-5 years (CTS5) tool could be used to determine whether patients should continue endocrine therapy 5 years after initial treatment.”